Ptosis: Clinical overview, etiology and treatment
DOI:
https://doi.org/10.12775/QS.2025.41.59951Keywords
ptosis, blepharoptosis, frontalis sling procedure, tarsoaponeurectomy, mullerectomyAbstract
Ptosis is a condition characterized by a low setting of the upper eyelid caused by congenital or acquired dysfunction of the levator muscle. The problem can occur unilaterally or bilaterally, in any age group, and affects over 1 million patients in Poland, with varying degrees of severity. Drooping of the upper eyelid leads to secondary restriction of the visual field, deterioration of vision quality, as well as a subjective decrease in visual acuity. Additionally, it is an aesthetic defect, which consequently negatively impacts the patient's quality of life, self-esteem, and social perception. This article presents key information about ptosis, including clinical implications, etiology, and classification, as well as diagnostic algorithms and methods, and modern surgical treatment approaches.
References
1. Sridharan GV, Tallis RC, Leatherbarrow B, Forman WM. A community survey of ptosis of the eyelid and pupil size of elderly people. Age Ageing. 1995 Jan;24(1):21-4. doi: 10.1093/ageing/24.1.21.
2. Kim MH, Cho J, Zhao D, Woo KI, Kim YD, Kim S, Yang SW. Prevalence and associated factors of blepharoptosis in Korean adult population: The Korea National Health and Nutrition Examination Survey 2008-2011. Eye (Lond). 2017 Jun;31(6):940-946. doi: 10.1038/eye.2017.43. Epub 2017 Mar 24.
3. Richards HS, Jenkinson E, Rumsey N, White P, Garrott H, Herbert H, Kalapesi F, Harrad RA. The psychological well-being and appearance concerns of patients presenting with ptosis. Eye (Lond). 2014 Mar;28(3):296-302. doi: 10.1038/eye.2013.264. Epub 2013 Dec 20.
4. Mokhtarzadeh A, Harrison AR. Controversies and advances in the management of congenital ptosis. Expert Rev Ophthalmol. 2015 Jan 2;10(1):59-63. doi: 10.1586/17469899.2015.991389. Epub 2014 Dec 12.
5. Pauly, Marian; Sruthi, R.. Ptosis: Evaluation and management. Kerala Journal of Ophthalmology 31(1):p 11-16, Jan–Apr 2019. | DOI: 10.4103/kjo.kjo_2_19
6. Latting MW, Huggins AB, Marx DP, Giacometti JN. Clinical Evaluation of Blepharoptosis: Distinguishing Age-Related Ptosis from Masquerade Conditions. Semin Plast Surg. 2017 Feb;31(1):5-16. doi: 10.1055/s-0037-1598188.
7. Finsterer J. Ptosis: causes, presentation, and management. Aesthetic Plast Surg. 2003 May-Jun;27(3):193-204. doi: 10.1007/s00266-003-0127-5. Epub 2003 Aug 21.
8. Meyer DR, Stern JH, Jarvis JM, Lininger LL. Evaluating the visual field effects of blepharoptosis using automated static perimetry. Ophthalmology. 1993 May;100(5):651-8; discussion 658-9. doi: 10.1016/s0161-6420(93)31593-9.
9. Maheshwari R, Maheshwari S. Muller's muscle resection for ptosis and relationship with levator and Muller's muscle function. Orbit. 2011 Jun;30(3):150-3. doi: 10.3109/01676831003666447.
10. Nair AG, Patil-Chhablani P, Venkatramani DV, Gandhi RA. Ocular myasthenia gravis: a review. Indian J Ophthalmol. 2014 Oct;62(10):985-91. doi: 10.4103/0301-4738.145987.
11. Shubhra G, Cat Nguyen B. Expert Techniques in Ophthalmic Surgery; Chapter-61 Ptosis Repair: Müllerectomy 2019.
12. Monsul NT, Patwa HS, Knorr AM, Lesser RL, Goldstein JM. The effect of prednisone on the progression from ocular to generalized myasthenia gravis. J Neurol Sci. 2004 Feb 15;217(2):131-3. doi: 10.1016/j.jns.2003.08.017.
13. Bacharach J, Lee WW, Harrison AR, Freddo TF. A review of acquired blepharoptosis: prevalence, diagnosis, and current treatment options. Eye (Lond). 2021 Sep;35(9):2468-2481. doi: 10.1038/s41433-021-01547-5. Epub 2021 Apr 29.
14. FASANELLA RM, SERVAT J. Levator resection for minimal ptosis: another simplified operation. Arch Ophthalmol. 1961 Apr;65:493-6. doi: 10.1001/archopht.1961.01840020495005.
15. Farber SE, Codner MA. Evaluation and management of acquired ptosis. Plast Aesthet Res. 2020;7:20. http://dx.doi.org/10.20517/2347-9264.2020.05
16. Beard C. The surgical treatment of blepharoptosis: a quantitative approach. Trans Am Ophthalmol Soc. 1966;64:401-87. PMID: 5337430; PMCID: PMC1310245.
17. Baldwin HC, Bhagey J, Khooshabeh R. Open sky Müller muscle-conjunctival resection in phenylephrine test-negative blepharoptosis patients. Ophthalmic Plast Reconstr Surg. 2005 Jul;21(4):276-80. doi: 10.1097/01.iop.0000167789.39570.3e.
18. McCord CD, Seify H, Codner MA. Transblepharoplasty ptosis repair: three-step technique. Plast Reconstr Surg. 2007 Sep 15;120(4):1037-1044. doi: 10.1097/01.prs.0000278000.36558.98.
19. Beyer-Machule CK. Congenital ptosis and complications of ptosis surgery. Plast Reconstr Surg. 1988 May;81(5):789-99. doi: 10.1097/00006534-198805000-00028.
20. Chang S, Lehrman C, Itani K, Rohrich RJ. A systematic review of comparison of upper eyelid involutional ptosis repair techniques: efficacy and complication rates. Plast Reconstr Surg. 2012 Jan;129(1):149-157. doi: 10.1097/PRS.0b013e318230a1c7. Erratum in: Plast Reconstr Surg. 2015 May;135(5):1507.
21. Codner MA, McCord DC, editors. Upper lid blepharoplasty. Eyelid and periorbital surgery. 2nd ed. New York: Thieme; 2017. pp. 229-56.
22. Pacella SJ, Codner MA. Minor complications after blepharoplasty: dry eyes, chemosis, granulomas, ptosis, and scleral show. Plast Reconstr Surg. 2010 Feb;125(2):709-718. doi: 10.1097/PRS.0b013e3181c830c7.
23. Lim JM, Hou JH, Singa RM, Aakalu VK, Setabutr P. Relative incidence of blepharoptosis subtypes in an oculoplastics practice at a tertiary care center. Orbit. 2013 Aug;32(4):231-4. doi: 10.3109/01676830.2013.788673. Epub 2013 May 10.
24. Satariano N, Brown MS, Zwiebel S, Guyuron B. Environmental factors that contribute to upper eyelid ptosis: a study of identical twins. Aesthet Surg J. 2015 Mar;35(3):235-41. doi: 10.1093/asj/sju070.
25. Godfrey KJ, Korn BS, Kikkawa DO. Blepharoptosis following ocular surgery: identifying risk factors. Curr Opin Ophthalmol. 2016 Jan;27(1):31-7. doi: 10.1097/ICU.0000000000000218.
26. Slonim CB, Foster S, Jaros M, Kannarr SR, Korenfeld MS, Smyth-Medina R, Wirta DL. Association of Oxymetazoline Hydrochloride, 0.1%, Solution Administration With Visual Field in Acquired Ptosis: A Pooled Analysis of 2 Randomized Clinical Trials. JAMA Ophthalmol. 2020 Nov 1;138(11):1168-1175. doi: 10.1001/jamaophthalmol.2020.3812.
27. Barsegian A, Botwinick A, Reddy HS. The Phenylephrine Test Revisited. Ophthalmic Plast Reconstr Surg. 2018 Mar/Apr;34(2):151-154. doi: 10.1097/IOP.0000000000000903.
28. Ophthalmic Plast Reconstr Surg. 2018 Mar/Apr;34(2):151-154. doi: 10.1097/IOP.0000000000000903.
29. Keene KR, Kan HE, van der Meeren S, Verbist BM, Tannemaat MR, Beenakker JM, Verschuuren JJGM. Clinical and imaging clues to the diagnosis and follow-up of ptosis and ophthalmoparesis. J Cachexia Sarcopenia Muscle. 2022 Dec;13(6):2820-2834. doi: 10.1002/jcsm.13089. Epub 2022 Sep 29.
30. Canepa C, Venu M. Progressive bilateral ophthalmoparesis--a case of simultaneous autoimmunity: balancing Graves' ophthalmoparesis and ocular myasthenia. BMJ Case Rep. 2016 Jan 4;2016:bcr2015213395. doi: 10.1136/bcr-2015-213395.
31. Akan O, Baysal-Kirac L. Ophthalmologic manifestations in myasthenia gravis: presentation and prognosis. Acta Neurol Belg. 2021 Oct;121(5):1131-1140. doi: 10.1007/s13760-020-01556-3. Epub 2021 Jan 4.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Adam Solarz, Szymon Szabelski, Katarzyna Skibicka, Estera Graczyk, Oliwia Cwalina, Joanna Kryślak, Maciej Sokołowski, Karolina Oskroba, Jakub Filip Turcza, Małgorzata Woś
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 106
Number of citations: 0
